These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator. Nordenswan HK; Pöyhönen P; Lehtonen J; Ekström K; Uusitalo V; Niemelä M; Vihinen T; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Alatalo A; Pietilä-Effati P; Kupari M Circulation; 2022 Sep; 146(13):964-975. PubMed ID: 36000392 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis. Kazmirczak F; Chen KA; Adabag S; von Wald L; Roukoz H; Benditt DG; Okasha O; Farzaneh-Far A; Markowitz J; Nijjar PS; Velangi PS; Bhargava M; Perlman D; Duval S; Akçakaya M; Shenoy C Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007488. PubMed ID: 31431050 [TBL] [Abstract][Full Text] [Related]
6. Arrhythmia in Cardiac Sarcoidosis. Locke AH; Gurin MI; Sabe M; Hauser TH; Zimetbaum P Cardiol Rev; 2021 May-Jun 01; 29(3):131-142. PubMed ID: 32941259 [TBL] [Abstract][Full Text] [Related]
7. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. Steckman DA; Schneider PM; Schuller JL; Aleong RG; Nguyen DT; Sinagra G; Vitrella G; Brun F; Cova MA; Pagnan L; Mestroni L; Varosy PD; Sauer WH Am J Cardiol; 2012 Aug; 110(4):575-9. PubMed ID: 22595349 [TBL] [Abstract][Full Text] [Related]
8. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis. Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203 [TBL] [Abstract][Full Text] [Related]
9. Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis. Yoshitomi R; Kobayashi S; Yano Y; Nakashima Y; Fujii S; Nanno T; Ishiguchi H; Fukuda M; Yoshiga Y; Okamura T; Suga K; Kawano R; Yano M Heart; 2022 Mar; 108(6):429-437. PubMed ID: 35078868 [TBL] [Abstract][Full Text] [Related]
10. The role of late gadolinium enhancement in predicting arrhythmic events in cardiac sarcoidosis patients - a mini-review. Bazoukis G; Liatakis I; Vassiliou VS; Tse G; Gounopoulos P; Saplaouras A; Letsas KP; Vlachos K; Papadatos SS; Konstantinidou E; Lakoumentas I; Sideris A; Efremidis M Acta Cardiol; 2022 Nov; 77(9):768-773. PubMed ID: 35086421 [TBL] [Abstract][Full Text] [Related]
11. Addressing the Risk of Ventricular Arrhythmias and Sudden Death in Patients With Cardiac Sarcoidosis. Patten RD; Shah SP Circulation; 2022 Sep; 146(13):976-979. PubMed ID: 36154617 [No Abstract] [Full Text] [Related]
12. Cardiac manifestations of sarcoidosis: diagnosis and management. Birnie DH; Kandolin R; Nery PB; Kupari M Eur Heart J; 2017 Sep; 38(35):2663-2670. PubMed ID: 27469375 [TBL] [Abstract][Full Text] [Related]
14. "Function follows form": Role of cardiac magnetic resonance for ventricular arrhythmia risk stratification in patients with cardiac sarcoidosis. Magnocavallo M; Vetta G; Polselli M; Cauti FM; Parlavecchio A; Caminiti R; Crea P; Pannone L; Sorgente A; Chimenti C; Chierchia GB; Rossi P; Natale A; de Asmundis C; Bianchi S; Della Rocca DG J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1781-1784. PubMed ID: 37493490 [TBL] [Abstract][Full Text] [Related]
15. Utility of electrophysiologic testing for sudden death risk stratification in cardiac sarcoidosis patients with mildly impaired left ventricular function. Tandon P; Mosleh T; Mustafa A; Miodownik H; Miller M; Morgenthau AS Respir Med; 2022 Jan; 191():106712. PubMed ID: 34906899 [TBL] [Abstract][Full Text] [Related]
16. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Mehta D; Mori N; Goldbarg SH; Lubitz S; Wisnivesky JP; Teirstein A Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):43-8. PubMed ID: 21193539 [TBL] [Abstract][Full Text] [Related]
18. Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy. O'Hara RP; Binka E; Prakosa A; Zimmerman SL; Cartoski MJ; Abraham MR; Lu DY; Boyle PM; Trayanova NA Elife; 2022 Jan; 11():. PubMed ID: 35076018 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of RV Abnormalities on CMR in Patients With Known or Suspected Cardiac Sarcoidosis. Wang J; Zhang J; Hosadurg N; Iwanaga Y; Chen Y; Liu W; Wan K; Patel AR; Wicks EC; Gkoutos GV; Han Y; Chen Y JACC Cardiovasc Imaging; 2023 Mar; 16(3):361-372. PubMed ID: 36752447 [TBL] [Abstract][Full Text] [Related]
20. Cardiac Sarcoidosis: A Clinical Overview. Alba AC; Gupta S; Kugathasan L; Ha A; Ochoa A; Balter M; Sosa Liprandi A; Sosa Liprandi MI; Curr Probl Cardiol; 2021 Oct; 46(10):100936. PubMed ID: 34400001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]